Importance of Genetic Testing
- Determines the effectiveness of anti-EGFR targeted therapy.
- Avoids ineffective treatments and unnecessary side effects.
- Provides the physician with insights into the tumor's biological behavior.
This advanced genetic panel identifies specific mutations in colorectal cancer, enabling your medical team to select the most effective targeted therapies and anti-EGFR treatments personalized to your unique genetic profile.
Scientific name: KRAS, NRAS, and BRAF Mutational Analysis
A precise molecular analysis detecting mutations in KRAS, NRAS, and BRAF genes. It determines eligibility for anti-EGFR targeted therapies in patients with metastatic colorectal cancer, ensuring highly personalized and effective treatment planning.